ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,416.90
0.51%
S&P ASX All Technology
3,999.30
1.15%
Brent Oil
75.84
-0.13%
US Dollar vs AUD
1.59505
-0.30%
Bitcoin
97,982.37
0.12%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Alpha Growth Plc (ALGW) Share Price

Alpha Growth Plc

Alpha Growth Plc (ALGW)

LSE
1.35
0.00
(0.00%)
Closed 05 February 3:30AM
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
1.35
Bid
1.30
Offer
1.60
Volume
0.00
0.00 Day's Range 0.00
1.10 52 Week Range 2.40
Market Cap
6.315M
Previous Close
1.35
Open
-
Last Trade
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
445,229
Shares Outstanding
467,775,068
Dividend Yield
-
PE Ratio
-4.66
Earnings Per Share (EPS)
-0
Revenue
5.21M
Net Profit
-1.36M

About Alpha Growth Plc

Sector
Management Consulting Svcs
Industry
Management Consulting Svcs
Website
www.algwplc.com
Headquarters
London, Gbr
Founded
-
Alpha Growth Plc is listed in the Management Consulting Svcs sector of the London Stock Exchange with ticker ALGW. The last closing price for Alpha Growth was 1.35p. Over the last year, Alpha Growth shares have traded in a share price range of 1.10p to 2.40p.

Alpha Growth currently has 467,775,068 shares in issue. The market capitalisation of Alpha Growth is £6.31 million. Alpha Growth has a price to earnings ratio (PE ratio) of -4.66.

Ask ADVFN Intelligence (AI)

ALGW Latest News

More News

Alpha Growth PLC New Accounting Reference Date

Alpha Growth PLC 23 December 2024     Alpha Growth plc ("Alpha" or the "Company") Change of Accounting Reference Date   Alpha Growth plc (LSE: ALGW and OTCQB: ALPGF), a leading financial...

24 December 2024
RNS Regulatory News

Alpha Growth PLC Non-Executive Director Appointment

Alpha Growth PLC 12 December 2024   Alpha Growth plc ("Alpha" or the "Company") Appointment of Non-Executive Director   Alpha Growth plc (LSE: ALGW and OTCQB: ALPGF), a leading financial...

12 December 2024
RNS Regulatory News

Alpha Growth PLC Holding(s) in Company

Alpha Growth PLC 27 September 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BYWKBC49 Issuer Name ALPHA GROWTH PLC UK or Non-UK Issuer UK 2. Reason...

27 September 2024
RNS Regulatory News

Alpha Growth PLC Half-year Report

Alpha Growth PLC 17 September 2024     THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW...

17 September 2024
RNS Regulatory News

Alpha Growth completes Jeometri buy following regulatory approval

Alpha Growth PLC on Monday confirmed regulatory approval for its acquisition of Jeometri Insurance Managers (Guernsey ...

09 September 2024
Alliance News

Alpha Growth PLC Acquisition

Alpha Growth PLC 09 September 2024   The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No...

09 September 2024
RNS Regulatory News

Alpha Growth PLC Result of AGM

Alpha Growth PLC 25 June 2024       Alpha Growth plc ("Alpha" or the "Company") Result of Annual General Meeting Alpha Growth Plc (LSE: ALGW and OTCQB: ALPGF), a leading financial services...

25 June 2024
RNS Regulatory News

Alpha Growth PLC Holding(s) in Company

Alpha Growth PLC 06 June 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BYWKBC49 Issuer Name ALPHA GROWTH PLC UK or Non-UK Issuer UK 2. Reason for...

06 June 2024
RNS Regulatory News

Alpha Growth to acquire majority stake insurance manager Jeometri

Alpha Growth PLC on Friday said it has struck a deal to acquire most of Jeometri Insurance Managers (Guernsey) Ltd, a ...

17 May 2024
Alliance News

Alpha Growth PLC Acquisition Insurance Services Company

Alpha Growth PLC 17 May 2024   The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulation (EU) No...

17 May 2024
RNS Regulatory News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.15-101.51.51.35996851.44058406DE
4-0.25-15.6251.61.61.354830931.48830908DE
12-0.5-27.0270270271.852.41.354452291.74963775DE
26-0.65-32.522.41.354664591.88616451DE
520.1512.51.22.41.16123831.79334326DE
156-1.05-43.752.43.41.0511635962.11811648DE
260-0.55-28.94736842111.98.050.9520296392.56561409DE

ALGW - Frequently Asked Questions (FAQ)

What is the current Alpha Growth share price?
The current share price of Alpha Growth is 1.35p
How many Alpha Growth shares are in issue?
Alpha Growth has 467,775,068 shares in issue
What is the market cap of Alpha Growth?
The market capitalisation of Alpha Growth is GBP 6.31M
What is the 1 year trading range for Alpha Growth share price?
Alpha Growth has traded in the range of 1.10p to 2.40p during the past year
What is the PE ratio of Alpha Growth?
The price to earnings ratio of Alpha Growth is -4.66
What is the cash to sales ratio of Alpha Growth?
The cash to sales ratio of Alpha Growth is 1.22
What is the reporting currency for Alpha Growth?
Alpha Growth reports financial results in GBP
What is the latest annual turnover for Alpha Growth?
The latest annual turnover of Alpha Growth is GBP 5.21M
What is the latest annual profit for Alpha Growth?
The latest annual profit of Alpha Growth is GBP -1.36M
What is the registered address of Alpha Growth?
The registered address for Alpha Growth is 35 BERKELEY STREET, LONDON, W1J 5BF
What is the Alpha Growth website address?
The website address for Alpha Growth is www.algwplc.com
Which industry sector does Alpha Growth operate in?
Alpha Growth operates in the MANAGEMENT CONSULTING SVCS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
0A2IH World Group Ltd
US$ 0.00
(0.00%)
0
0A2DCrh Plc
US$ 0.00
(0.00%)
0
0A2BBanco Bilbao Vizcaya Argentaria Sa
US$ 0.00
(0.00%)
0
0A22Anheuser Busch Inbev Nv
US$ 0.00
(0.00%)
0
0A1UUber Technologies Inc
US$ 69.50
(0.00%)
1.71k
0A2IH World Group Ltd
US$ 0.00
(0.00%)
0
0A2DCrh Plc
US$ 0.00
(0.00%)
0
0A2BBanco Bilbao Vizcaya Argentaria Sa
US$ 0.00
(0.00%)
0
0A22Anheuser Busch Inbev Nv
US$ 0.00
(0.00%)
0
0A1UUber Technologies Inc
US$ 69.50
(0.00%)
1.71k
STXShield Therapeutics Plc
2.85p
(0.00%)
150k
0RIHAlphabet Inc
US$ 205.30
(0.00%)
11.71k
0HD6Alphabet Inc
US$ 207.20
(0.00%)
8.07k
0HCIAlibaba Group Holding Ltd
US$ 103.70
(0.00%)
7.86k
0R24Intel Corp
US$ 19.575
(0.00%)
6.79k

Discussion

View Full Feed
zino zino 2 minutes ago
if we get the right Quant Merger this will explode and also
could turn turn into be a potential Nasdaq uplisting
Just look at RgtI and its run and the money it easily raised
GCAN
pgsd pgsd 6 minutes ago
Typical for anything related to DCVax lol

It is included in the list of Proposed 24-25 HC Drugs:

In the alphabetic order from the list it is listed as 'Brain cancer vaccine' which is then crossed out and Murcidencel is added...

https://investorshub.advfn
NWBO
muee88 muee88 7 minutes ago
Also, the Proposed 24-25 HC drug list is alphabetical, but Murcidencel is listed under the Bs because “Brain Cancer Vaccine” is crossed out and replaced with Murcidencel.
NWBO
TurboMountain96 TurboMountain96 7 minutes ago
Frankly, we are the original MEGA, Make Elite Great Again. We had that slogan long before Trump entered politics or plagiarized from Ronald Reagan, who originally started Make America Great Again. So to that end, maybe to support the stockholders, our MEGA, we’re going to build a wall of needle move
ELTP
RichieBoy RichieBoy 9 minutes ago
Only stating the patently obvious here...

When AFFU's dilution stops, the share price contraction stops. Just that simple. I get a strong sense the company is intentionally stalling for that reason. Mike Balkin and AFFU's other board member(s?) don't want to waste material event comp
AFFU
OnTrack444 OnTrack444 10 minutes ago

Is this your newest made pump account with a 122 followers on X?   😂   Total comedy 🎭 

How much do they pay you to pump bloated pigs because you cer
HMBL
muee88 muee88 13 minutes ago
Unfortunately, I don’t know how to upload a screenshot to this antiquated website —it shouldn’t be this difficult. I can assure you I’m not lying. Also, an email can be faked too so I’m not really sure what a screenshot would tell you.

However, here’s essentially the full text of the
NWBO
123tom 123tom 15 minutes ago
Steve, what you're saying about AVXL price movement not holding the support levels you'd expect... that's something I've watched AVXL do for 14 years. It's what I call the "bleeding down game". I always expect to see lower lows than we ought to see. Even in bullish upwave patterns.... the seller
AVXL
muee88 muee88 19 minutes ago
You need to click the tap entitled “Proposed 24-25 HC drugs.” On my phone, the tab I’m talking about is shown across the top of the website.
NWBO
skitahoe skitahoe 21 minutes ago
When I use your link I get a list of their hospitals, not drugs, am I doing something wrong, or is there a problem with the link.

Thanks,

Gary
NWBO
roadkilll roadkilll 26 minutes ago
Why central banks’ hunger for gold shows ‘no sign of being quelled’ this year
Published: Feb. 5, 2025

Central banks, as well as exchange-traded-fund investors, are likely to drive gold demand this year, with economic uncertainty supporting gold’s role as a risk hedge, the Worl
IAG
demonsmith demonsmith 26 minutes ago
There working on it noting going to happen intell after shareholder metting
TWOH
roadkilll roadkilll 29 minutes ago
Tesla hasn't paid taxes in 3 years
200 P/E
5.5 PEG
$7500 taxpayer from taxpayers to anyone buying a new Tesla
$4000 taxpayer funded payment anyone buying a used Tesla to keep the flow going
30% taxpayer funding to anyone that instals a home battery unit ($3000 if y
TSLA
bluebird50 bluebird50 30 minutes ago
I had a 50 share marker on this and sold it first thing Monday morning.... 

Not feeling good here.... 
pharmas have huge upswings with steady declines!!!  

Time it ladies and gentlemen! 
TNXP
Seminole Red Seminole Red 30 minutes ago
LOLOL
DJPele DJPele 32 minutes ago
Muee, apologies for being persistent, but can you provide a screenshot of the email from the MHRA?
NWBO
muee88 muee88 39 minutes ago
I asked ChatGPT what it meant:

Me: Does Murcidencel being on this list imply that this drug is going to be approved for a marketing authorization?

ChatGPT:

No, the inclusion of Mircidencel on the NHS Proposed 24-25 High-Cost Drugs List does not necessaril
NWBO
muee88 muee88 54 minutes ago
What does Murcidencel being included on this list of “High cost drugs - proposed list for 2024/25” mean?

https://www.england.nhs.uk/wp-content/uploads/2023/12/23-25NHSPS-amendment-consultation-annex.xlsx
NWBO
Werbe Werbe 59 minutes ago
Let's get a pr about future intentions, how we make this a $50 m cap company.  I think we can achieve that at least.
ATWT
Seminole Red Seminole Red 59 minutes ago
100 feet in difference is only 33 yards, thats pretty close for two vehicles in the air
DocLee DocLee 60 minutes ago
HI, DH. Sorry, I don't know whether anybody has contacted either NWBO or the MHRA but you could do it yourself. That would be a much easier option than trawling through tens (or even hundreds) of thousands of messages on this board that have been posted since the MHRA started its assessments. Bes
NWBO
chereb19 chereb19 1 hour ago
The primary objective of this phase I trial is to assess the safety and feasibility of the treatment.
Notably, one patient experienced an exceptional 80% reduction in tumor size during this trial so far. Such a significant response is uncommon in phase I trials, which are primarily designed t
RDGL
trader53 trader53 1 hour ago
DPLS 0.00055 - ALERTING STRONG BUY!


DPLS - Company Update with CEO 2/13/2025
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175756306

DPLS 0.0006 - ALERTING STRONG BUY!
https://investorshub.advfn.com/boards/read_msg.aspx?mess
DPLS MFI

Your Recent History

LSE
ALGW
Alpha Growth
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads